Annual Working Capital
$80.67 M
-$29.36 M-26.69%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual working capital is $80.67 million, with the most recent change of -$29.36 million (-26.69%) on December 31, 2023.
- During the last 3 years, LRMR annual working capital has fallen by -$8.29 million (-9.32%).
- LRMR annual working capital is now -26.69% below its all-time high of $110.03 million, reached on December 31, 2022.
Performance
LRMR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$196.97 M
-$13.00 M-6.19%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly working capital is $196.97 million, with the most recent change of -$13.00 million (-6.19%) on September 30, 2024.
- Over the past year, LRMR quarterly working capital has dropped by -$13.00 million (-6.19%).
- LRMR quarterly working capital is now -9.69% below its all-time high of $218.11 million, reached on March 31, 2024.
Performance
LRMR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
LRMR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.7% | -6.2% |
| 3 y3 years | -9.3% | -6.2% |
| 5 y5 years | +7145.3% | -6.2% |
LRMR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | +27.3% | -9.7% | +301.8% |
| 5 y | 5-year | -26.7% | +7145.3% | -9.7% | >+9999.0% |
| alltime | all time | -26.7% | +7145.3% | -9.7% | >+9999.0% |
Larimar Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $196.97 M(-6.2%) |
| Jun 2024 | - | $209.97 M(-3.7%) |
| Mar 2024 | - | $218.11 M(+170.4%) |
| Dec 2023 | $80.67 M(-26.7%) | $80.67 M(-12.2%) |
| Sep 2023 | - | $91.92 M(-7.3%) |
| Jun 2023 | - | $99.20 M(-5.9%) |
| Mar 2023 | - | $105.45 M(-4.2%) |
| Dec 2022 | $110.03 M | $110.03 M(-6.5%) |
| Sep 2022 | - | $117.71 M(+140.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $49.02 M(-12.5%) |
| Mar 2022 | - | $56.01 M(-11.6%) |
| Dec 2021 | $63.36 M(-28.8%) | $63.36 M(-10.7%) |
| Sep 2021 | - | $70.95 M(+6.9%) |
| Jun 2021 | - | $66.34 M(-14.7%) |
| Mar 2021 | - | $77.75 M(-12.6%) |
| Dec 2020 | $88.96 M(-7869.4%) | $88.96 M(-13.3%) |
| Sep 2020 | - | $102.64 M(-8.7%) |
| Jun 2020 | - | $112.47 M(<-9900.0%) |
| Dec 2019 | -$1.15 M | -$1.15 M |
FAQ
- What is Larimar Therapeutics annual working capital?
- What is the all time high annual working capital for Larimar Therapeutics?
- What is Larimar Therapeutics annual working capital year-on-year change?
- What is Larimar Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly working capital year-on-year change?
What is Larimar Therapeutics annual working capital?
The current annual working capital of LRMR is $80.67 M
What is the all time high annual working capital for Larimar Therapeutics?
Larimar Therapeutics all-time high annual working capital is $110.03 M
What is Larimar Therapeutics annual working capital year-on-year change?
Over the past year, LRMR annual working capital has changed by -$29.36 M (-26.69%)
What is Larimar Therapeutics quarterly working capital?
The current quarterly working capital of LRMR is $196.97 M
What is the all time high quarterly working capital for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly working capital is $218.11 M
What is Larimar Therapeutics quarterly working capital year-on-year change?
Over the past year, LRMR quarterly working capital has changed by -$13.00 M (-6.19%)